Back to today’s briefing

Story perspectives

Promising Weight Loss and Health Benefits from Liraglutide

5/20/2025

33 5

Summary

Story summary

Dr. Amir Meftah and his team uncovered promising results in their review of GLP-1 receptor agonists for patients on antipsychotics like clozapine and olanzapine. They found that liraglutide not only enhanced glucose tolerance but also led to significant reductions in body weight, waist size, and LDL cholesterol. Meftah urges the necessity for larger trials to validate these encouraging findings.

1 of 1

Story summary

Dr. Amir Meftah and his team uncovered promising results in their review of GLP-1 receptor agonists for patients on antipsychotics like clozapine and olanzapine. They found that liraglutide not only enhanced glucose tolerance but also led to significant reductions in body weight, waist size, and LDL cholesterol. Meftah urges the necessity for larger trials to validate these encouraging findings.